These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 1827427)
1. Algammulin (gamma inulin/alum hybrid adjuvant) has greater adjuvanticity than alum for hepatitis B surface antigen in mice. Cooper PD; Turner R; McGovern J Immunol Lett; 1991 Feb; 27(2):131-4. PubMed ID: 1827427 [TBL] [Abstract][Full Text] [Related]
2. The adjuvanticity of Algammulin, a new vaccine adjuvant. Cooper PD; McComb C; Steele EJ Vaccine; 1991 Jun; 9(6):408-15. PubMed ID: 1887671 [TBL] [Abstract][Full Text] [Related]
3. Humoral immune responses in mice using gamma inulin preparations as adjuvants for hepatitis B vaccines. Leslie DE; Nicholson S; Dimitrakakis M; Johnston N; Gust ID Immunol Cell Biol; 1990 Apr; 68 ( Pt 2)():107-12. PubMed ID: 1696560 [TBL] [Abstract][Full Text] [Related]
4. Algammulin, a new vaccine adjuvant comprising gamma inulin particles containing alum: preparation and in vitro properties. Cooper PD; Steele EJ Vaccine; 1991 May; 9(5):351-7. PubMed ID: 1872020 [TBL] [Abstract][Full Text] [Related]
5. Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies. Weeratna RD; Brazolot Millan CL; McCluskie MJ; Siegrist CA; Davis HL FEMS Immunol Med Microbiol; 2001 Apr; 30(3):241-7. PubMed ID: 11335145 [TBL] [Abstract][Full Text] [Related]
6. MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates. Traquina P; Morandi M; Contorni M; Van Nest G J Infect Dis; 1996 Dec; 174(6):1168-75. PubMed ID: 8940205 [TBL] [Abstract][Full Text] [Related]
7. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA. McCluskie MJ; Weeratna RD; Payette PJ; Davis HL FEMS Immunol Med Microbiol; 2002 Feb; 32(3):179-85. PubMed ID: 11934561 [TBL] [Abstract][Full Text] [Related]
8. RLJ-NE-299A: a new plant based vaccine adjuvant. Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726 [TBL] [Abstract][Full Text] [Related]
9. Vaccine adjuvants based on gamma inulin. Cooper PD Pharm Biotechnol; 1995; 6():559-80. PubMed ID: 7551236 [TBL] [Abstract][Full Text] [Related]
10. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice]. Chen H; Deng Y; Tan W; Wang W; Yin X; Guan J; Wang W; Ruan L Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):74-8. PubMed ID: 20353095 [TBL] [Abstract][Full Text] [Related]
11. CPG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB/c mice. Weeratna R; Comanita L; Davis HL Immunol Cell Biol; 2003 Feb; 81(1):59-62. PubMed ID: 12534947 [TBL] [Abstract][Full Text] [Related]
12. Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in mice. Grenfell RF; Shollenberger LM; Samli EF; Harn DA Clin Vaccine Immunol; 2015 Mar; 22(3):336-43. PubMed ID: 25609075 [TBL] [Abstract][Full Text] [Related]
13. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine. Fakharzadeh S; Kalanaky S; Hafizi M; Goya MM; Masoumi Z; Namaki S; Shakeri N; Abbasi M; Mahdavi M; Nazaran MH Vaccine; 2013 May; 31(22):2591-7. PubMed ID: 23583463 [TBL] [Abstract][Full Text] [Related]
14. A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing. Saade F; Honda-Okubo Y; Trec S; Petrovsky N Vaccine; 2013 Apr; 31(15):1999-2007. PubMed ID: 23306367 [TBL] [Abstract][Full Text] [Related]
15. The influence of gamma inulin and Algammulin on the immune response in sheep to a recombinant antigen of Taenia ovis. Deol HS; Palmer DG; Dunsmore T; Carnegie PR Vaccine; 1995 Apr; 13(5):429-33. PubMed ID: 7639010 [TBL] [Abstract][Full Text] [Related]
16. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses. Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines. Xiao W; Du L; Liang C; Guan J; Jiang S; Lustigman S; He Y; Zhou Y Vaccine; 2008 Sep; 26(39):5022-9. PubMed ID: 18675867 [TBL] [Abstract][Full Text] [Related]
18. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen. Xie Y; Sun HX; Li D Vaccine; 2009 Jan; 27(5):757-64. PubMed ID: 19041358 [TBL] [Abstract][Full Text] [Related]
19. Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantation. Scheiblhofer S; Strobl A; Hoepflinger V; Thalhamer T; Steiner M; Thalhamer J; Weiss R Vaccine; 2017 Mar; 35(14):1802-1809. PubMed ID: 28117172 [TBL] [Abstract][Full Text] [Related]
20. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice. Weeratna RD; Brazolot Millan CL; McCluskie MJ; Davis HL FEMS Immunol Med Microbiol; 2001 Dec; 32(1):65-71. PubMed ID: 11750224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]